Biostem Technologies Inc (BSEM)

Currency in USD
11.5200
+0.1600(+1.41%)
Closed·
BSEM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BSEM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.100011.8600
52 wk Range
6.950028.2565
Key Statistics
Prev. Close
11.36
Open
11.4
Day's Range
11.1-11.86
52 wk Range
6.95-28.2565
Volume
40.74K
Average Volume (3m)
55.51K
1-Year Change
25.9%
Book Value / Share
2.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BSEM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low revenue valuation multiple

Biostem Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Biostem Technologies Inc Company Profile

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Employees
33

Biostem Technologies Inc Earnings Call Summary for Q1/2025

  • Biostem Tech missed Q1 2025 forecasts: EPS of $0.27 vs $0.51 expected, revenue of $72.5M vs $82.5M projected
  • Revenue grew 73% YoY to $72.5M, marking strongest Q1 in company history; fifth consecutive profitable quarter
  • Stock rose 0.55% post-earnings; company appears undervalued per InvestingPro analysis
  • No specific guidance provided; focus on expanding Vendahe AC, operational efficiencies, and clinical validation
  • Challenges noted in chronic wound care market due to LCD implementation; DFU trial enrollment nearly complete
Last Updated: 12/05/2025, 22:18
Read Full Transcript

Compare BSEM to Peers and Sector

Metrics to compare
BSEM
Peers
Sector
Relationship
P/E Ratio
5.6x−3.2x−0.5x
PEG Ratio
0.000.000.00
Price/Book
3.9x2.8x2.6x
Price / LTM Sales
0.6x2.2x3.3x
Upside (Analyst Target)
206.0%120.9%42.4%
Fair Value Upside
Unlock19.2%7.2%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.27 / 0.51
Revenue / Forecast
72.53M / 82.50M
EPS Revisions
Last 90 days

BSEM Income Statement

People Also Watch

5.420
CVAC
+0.18%
25.79
CNC
+1.02%
128.87
ALAB
+8.83%
50.510
SMR
+3.14%
106.10
HOOD
+2.69%

FAQ

What Stock Exchange Does Biostem Tech Trade On?

Biostem Tech is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Biostem Tech?

The stock symbol for Biostem Tech is "BSEM."

What Is the Biostem Tech Market Cap?

As of today, Biostem Tech market cap is 190.23M.

What Is Biostem Tech's Earnings Per Share (TTM)?

The Biostem Tech EPS (TTM) is 2.01.

When Is the Next Biostem Tech Earnings Date?

Biostem Tech will release its next earnings report on 25 Aug 2025.

From a Technical Analysis Perspective, Is BSEM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Biostem Tech Stock Split?

Biostem Tech has split 5 times.

How Many Employees Does Biostem Tech Have?

Biostem Tech has 33 employees.

What is the current trading status of Biostem Tech (BSEM)?

As of 31 Jul 2025, Biostem Tech (BSEM) is trading at a price of 11.52, with a previous close of 11.36. The stock has fluctuated within a day range of 11.10 to 11.86, while its 52-week range spans from 6.95 to 28.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.